Mitral repair is superior to replacement when associated with coronary artery disease

T Brett Reece1, Curtis G Tribble, Peter I Ellman

  • 1Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia Health Sciences Center, MR$ Building, Room 3116, Charlottesville, VA 22908, USA. tbr5q@virginia.edu

Annals of Surgery
|April 15, 2004
PubMed

Insights

Mitral repair offers better outcomes than replacement in patients needing both coronary artery bypass grafting and mitral valve surgery. Repair significantly reduces hospital mortality and complications compared to replacement in ischemic mitral regurgitation.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Repair and Replacement
  • Ischemic Mitral Regurgitation

Background:

  • Combined coronary artery bypass grafting (CABG) and mitral procedures carry high mortality rates (>10%).
  • Mitral valve replacement (MVR) with subvalvular apparatus preservation may offer comparable results to mitral repair in CABG patients.

Purpose of the Study:

  • To compare the perioperative outcomes of mitral valve repair versus replacement in patients undergoing concurrent CABG for ischemic mitral regurgitation.
  • To evaluate hospital mortality and complication rates, including infection, stroke, pulmonary, and renal issues.

Main Methods:

  • A retrospective study comparing 54 patients who underwent CABG/mitral repair with 56 patients who had CABG/MVR (subvalvular sparing) over seven years.
  • Patient groups were similar in age (mean 67-69 years).
  • Outcomes assessed included hospital mortality, infection, stroke, pulmonary complications, and renal complications.

Main Results:

  • Mitral repair group showed significantly lower hospital mortality (1.9% vs. 10.7%, P=0.05).
  • No significant differences were observed in infection rates (9% vs. 13%), stroke incidence (2 vs. 2), pulmonary complications (39% vs. 32%), or renal complications (15% vs. 18%).

Conclusions:

  • Mitral repair is superior to mitral replacement in patients with coronary artery disease and ischemic mitral regurgitation, offering improved perioperative morbidity and reduced hospital mortality.
  • Despite theoretical advantages of MVR with subvalvular preservation, mitral repair provides a clear survival benefit in this patient population.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...